Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-057555
Filing Date
2008-03-14
Accepted
2008-03-14 17:09:54
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 910315
2 FIRST AMENDMENT TO LEASE AGREEMENT dex1045.htm EX-10.45 20801
3 SUSIDIARIES OF CARDIUM THERAPEUTICS, INC. dex21.htm EX-21 2496
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2068
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 5968
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 5947
7 SECTION 1350 CERTIFICATION dex32.htm EX-32 3497
8 GRAPHIC g76096g13l80.jpg GRAPHIC 35894
9 GRAPHIC g76096g45k39.jpg GRAPHIC 27183
  Complete submission text file 0001193125-08-057555.txt   1040002
Mailing Address 3611 VALLEY CENTRE DRIVE, SUITE 525 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE, SUITE 525 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

EIN.: 840635673 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33635 | Film No.: 08690287
SIC: 2836 Biological Products, (No Diagnostic Substances)